Highlights

MWC technical excellence helps NZ attract new medicines

MWC technical excellence helps NZ attract new medicines

A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.

read the full story

Nationwide research flagship takes fight to global viral threats

Nationwide research flagship takes fight to global viral threats

A growing network of Maurice Wilkins Centre investigators around New Zealand are collaborating on research to tackle importa...

read the full story

Developing a vaccine to prevent rheumatic fever

Developing a vaccine to prevent rheumatic fever

Group A Streptococcus (GAS) infection is widespread around the world, but causes particularly serious complications in New Ze...

read the full story

Mid-term review sets future direction

Mid-term review sets future direction

A comprehensive independent assessment found the Centre to be performing at a high level, producing distinct and positive ben...

read the full story

Smarter drug design

Smarter drug design

An advanced experimental technique linked to high powered computation is becoming an increasingly important tool for MWC rese...

read the full story

High-impact publications highlight TB research

High-impact publications highlight TB research

Researchers in the MWC’s Tuberculosis Flagship Research Programme have had their long hours in the lab recognised through pub...

read the full story

Investigating a bacterial 'master' of disguise

Investigating a bacterial 'master' of disguise

MWC researchers have revealed a unique protein in a common bacterium that helps it disguise itself from immune attack. This d...

read the full story

Re-thinking the causes of rheumatic fever

Re-thinking the causes of rheumatic fever

Researchers and health professionals are re-thinking the causes of rheumatic fever after studies by Maurice Wilkins Centre in...

read the full story

Early career researchers zoom in on an important drug target

Early career researchers zoom in on an important drug target

An estimated 1.3 million people die from tuberculosis (TB) each year, and new drugs are desperately needed, especially as res...

read the full story